Comments and Suggestions from Pain Specialists Regarding the CDC's Proposed Opioid Guidelines

Pain Pract. 2016 Sep;16(7):794-808. doi: 10.1111/papr.12475.

Joseph V Pergolizzi Jr^{1

2}, Robert B Raffa^{3

4}, Gianpietro Zampogna^{5

6}, Frank Breve^{7

8}, Robert Colucci⁹, William K Schmidt¹⁰, Jo Ann LeQuang⁵

¹ Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A.
² Department of Pharmacology, Temple University School of Medicine, Philadelphia, Pennsylvania, U.S.A.
³ Department of Pharmacology and Toxicology, University of Arizona College of Pharmacy, Tucson, Arizona, U.S.A.
⁴ Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania, U.S.A.
⁵ NEMA Research, Inc., Naples, Florida, U.S.A.
⁶ Department of Medicine, St. Vincent Charity Medical Center/Case Western Reserve University School of Medicine, Cleveland, Ohio, U.S.A.
⁷ Department of Pharmacy Practice, Temple University School of Pharmacy, Philadelphia, Pennsylvania, U.S.A.
⁸ Mid Atlantic PharmaTech Consultants, LLC, Ventnor City, New Jersey, U.S.A.
⁹ Colucci & Associates, LLC, Newtown, Connecticut, U.S.A.
¹⁰ NorthStar Consulting LLC, Davis, California, U.S.A.

No abstract available

Publication types